title: Trial watch: antibody-drug conjugate shows efficacy in lymphoma.
mesh_terms: D000079963:Brentuximab Vedotin; D017322:Clinical Trials, Phase II as Topic / Q000639:trends*; D006801:Humans; D018796:Immunoconjugates / Q000276:immunology / Q000627:therapeutic use*; D008223:Lymphoma / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin